West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$385.73 USD
-4.47 (-1.15%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $386.10 +0.37 (0.10%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
WST 385.73 -4.47(-1.15%)
Will WST be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Other News for WST
West Pharmaceutical Q1 2024 Earnings Preview
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors
Dividend Champion, Contender, And Challenger Highlights: Week Of April 21
Noteworthy Friday Option Activity: WST, ATGE, VKTX
Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry